ABVC Financial Statements

Balance sheet, income statement, cash flow, and dividends for Abvc Biopharma Inc (ABVC).


$8.39M Market Cap.

As of 03/13/2024 5:00 PM ET (MRY) • Disclaimer

ABVC Market Cap. (MRY)


ABVC Shares Outstanding (MRY)


ABVC Assets (MRY)


Total Assets

$14.49M

Total Liabilities

$6.36M

Total Investments

$2.61M

ABVC Income (MRY)


Revenue

$152.43K

Net Income

-$10.52M

Operating Expense

$8.07M

ABVC Cash Flow (MRY)


CF Operations

-$4.24M

CF Investing

-$360.19K

CF Financing

$3.92M

ABVC Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

0%

0%

-

2019

$0

-

-

0%

-

ABVC Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

$14,492,599 (51.29%)

$9,579,574 (-30.07%)

$13,698,033 (18.02%)

$11,606,705 (67.54%)

Assets Current

$1,656,709 (-44.54%)

$2,987,247 (-60.97%)

$7,653,782 (23.99%)

$6,172,966 (602.88%)

Assets Non-Current

$12,835,890 (94.71%)

$6,592,327 (9.07%)

$6,044,251 (11.24%)

$5,433,739 (-10.18%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$8,388,050 (170.71%)

$3,098,585 (-64.96%)

$8,843,653 (157.21%)

$3,438,340 (2377.59%)

Property Plant & Equipment Net

$8,778,561 (405.93%)

$1,735,119 (-13.15%)

$1,997,780 (-12.67%)

$2,287,581 (118.83%)

Cash & Equivalents

$716,780 (-48.50%)

$1,391,728 (-78.80%)

$6,565,215 (31.27%)

$5,001,371 (3017.23%)

Accumulated Other Comprehensive Income

$516,387 (-0.14%)

$517,128 (-4.18%)

$539,660 (-4.46%)

$564,860 (-14.90%)

Deferred Revenue

$79,500 (623.71%)

$10,985 (0%)

$0 (0%)

$0 (0%)

Total Investments

$2,607,052 (184.03%)

$917,867 (-11.82%)

$1,040,902 (-12.58%)

$1,190,727 (-64.61%)

Investments Current

$79,312 (4.64%)

$75,797 (-29.91%)

$108,147 (0%)

$0 (0%)

Investments Non-Current

$2,527,740 (200.18%)

$842,070 (-9.72%)

$932,755 (-21.67%)

$1,190,727 (-64.61%)

Inventory

$0 (0%)

$0 (0%)

$25,975 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$759,566 (-66.01%)

$2,234,964 (424.53%)

$426,091 (-57.37%)

$999,402 (56.03%)

Trade & Non-Trade Payables

$173,132 (-51.91%)

$359,992 (-8.50%)

$393,424 (26.30%)

$311,489 (-30.73%)

Accumulated Retained Earnings (Deficit)

-$65,420,095 (-19.15%)

-$54,904,439 (-42.68%)

-$38,481,200 (-50.07%)

-$25,642,387 (-61.77%)

Tax Assets

$0 (0%)

$117,110 (-88.07%)

$981,912 (-45.16%)

$1,790,597 (22.64%)

Tax Liabilities

$112,946 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$2,277,989 (-25.43%)

$3,054,891 (-1.83%)

$3,111,899 (-52.00%)

$6,482,945 (41.57%)

Debt Current

$1,870,532 (-17.35%)

$2,263,064 (13.89%)

$1,987,100 (-17.27%)

$2,401,978 (-44.70%)

Debt Non-Current

$407,457 (-48.54%)

$791,827 (-29.60%)

$1,124,799 (-72.44%)

$4,080,967 (1632.49%)

Total Liabilities

$6,361,627 (0.29%)

$6,343,435 (31.40%)

$4,827,691 (-46.03%)

$8,944,638 (26.83%)

Liabilities Current

$5,932,490 (7.01%)

$5,543,628 (50.14%)

$3,692,312 (-23.78%)

$4,844,391 (-28.91%)

Liabilities Non-Current

$429,137 (-46.34%)

$799,807 (-29.56%)

$1,135,379 (-72.31%)

$4,100,247 (1619.65%)

ABVC Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

$152,430 (-84.28%)

$969,783 (172.57%)

$355,797 (-26.34%)

$483,045 (-31.16%)

Cost of Revenue

$302,037 (5.45%)

$286,415 (5531.44%)

$5,086 (-72.83%)

$18,716 (-7.06%)

Selling General & Administrative Expense

$5,368,278 (-11.52%)

$6,067,545 (5.59%)

$5,746,119 (34.46%)

$4,273,468 (39.22%)

Research & Development Expense

$1,062,916 (-60.54%)

$2,693,457 (168.32%)

$1,003,805 (82.62%)

$549,658 (-47.58%)

Operating Expenses

$8,066,902 (-48.94%)

$15,797,780 (31.03%)

$12,056,679 (34.41%)

$8,970,105 (116.65%)

Interest Expense

$2,493,340 (748.17%)

$293,968 (29.38%)

$227,210 (-43.90%)

$405,032 (-15.97%)

Income Tax Expense

$256,006 (-67.91%)

$797,778 (-3.30%)

$825,024 (474.41%)

-$220,352 (-186.02%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$10,910,288 (33.12%)

-$16,312,374 (-35.53%)

-$12,035,851 (-13.61%)

-$10,593,584 (-169.33%)

Net Income to Non-Controlling Interests

-$394,632 (-455.96%)

$110,865 (-86.19%)

$802,962 (200.07%)

-$802,420 (-175.31%)

Net Income

-$10,515,656 (35.97%)

-$16,423,239 (-27.92%)

-$12,838,813 (-31.13%)

-$9,791,164 (-168.86%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$10,515,656 (35.97%)

-$16,423,239 (-27.92%)

-$12,838,813 (-31.13%)

-$9,791,164 (-168.86%)

Weighted Average Shares

$4,335,650 (36.92%)

$3,166,466 (26.39%)

$2,505,352 (27.07%)

$1,971,556 (12.67%)

Weighted Average Shares Diluted

$4,335,650 (36.92%)

$3,166,466 (26.39%)

$2,505,352 (27.07%)

$1,971,556 (12.67%)

Earning Before Interest & Taxes (EBIT)

-$7,766,310 (49.34%)

-$15,331,493 (-30.08%)

-$11,786,579 (-22.69%)

-$9,606,484 (-196.79%)

Gross Profit

-$149,607 (-121.89%)

$683,368 (94.85%)

$350,711 (-24.47%)

$464,329 (-31.87%)

Operating Income

-$8,216,509 (45.64%)

-$15,114,412 (-29.12%)

-$11,705,968 (-37.62%)

-$8,505,776 (-145.92%)

ABVC Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

-$360,186 (79.08%)

-$1,721,684 (-113.62%)

-$805,966 (-257.52%)

-$225,431 (-538.67%)

Net Cash Flow from Financing

$3,918,960 (-2.37%)

$4,013,925 (-59.84%)

$9,995,550 (4.47%)

$9,567,843 (209.89%)

Net Cash Flow from Operations

-$4,235,845 (42.75%)

-$7,398,391 (2.62%)

-$7,597,719 (-66.47%)

-$4,563,919 (-45.60%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$674,948 (86.95%)

-$5,173,487 (-430.82%)

$1,563,844 (-67.70%)

$4,840,928 (5979.34%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

-$373,235 (-2033.26%)

Net Cash Flow - Investment Acquisitions and Disposals

-$338,985 (78.84%)

-$1,601,992 (-103.18%)

-$788,463 (-633.45%)

$147,804 (930.31%)

Capital Expenditure

-$21,201 (82.29%)

-$119,692 (-583.84%)

-$17,503 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$462,622 (32.18%)

$350,000 (227.98%)

-$273,473 (-114.01%)

$1,952,512 (-2.54%)

Issuance (Purchase) of Equity Shares

$3,456,338 (-5.67%)

$3,663,925 (-67.05%)

$11,119,452 (46.01%)

$7,615,331 (1333.75%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$2,123 (103.15%)

-$67,337 (-140.31%)

-$28,021 (-144.88%)

$62,435 (1560975.00%)

Share Based Compensation

$1,635,708 (-76.75%)

$7,036,778 (32.60%)

$5,306,755 (27.97%)

$4,146,979 (18484.65%)

Depreciation Amortization & Accretion

$28,531 (19.88%)

$23,799 (98.44%)

$11,993 (-67.71%)

$37,142 (-32.57%)

ABVC Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

-98.10% (-239.15%)

70.50% (-28.50%)

98.60% (2.60%)

96.10% (-1.03%)

Profit Margin

-6898.70% (-307.36%)

-1693.50% (53.07%)

-3608.50% (-78.02%)

-2027.00% (-290.56%)

EBITDA Margin

-5076.30% (-221.59%)

-1578.50% (52.30%)

-3309.40% (-67.06%)

-1981.00% (-336.92%)

Return on Average Equity (ROAE)

-224.00% (12.09%)

-254.80% (-6.43%)

-239.40% (59.81%)

-595.70%

Return on Average Assets (ROAA)

-82.30% (42.49%)

-143.10% (-26.86%)

-112.80% (-6.72%)

-105.70%

Return on Sales (ROS)

-5095.00% (-222.28%)

-1580.90% (52.28%)

-3312.70% (-66.58%)

-1988.70% (-331.11%)

Return on Invested Capital (ROIC)

-76.30% (61.68%)

-199.10% (-36.18%)

-146.20% (2.79%)

-150.40%

Dividend Yield

0% (0%)

0% (0%)

0%

-

Price to Earnings Ratio (P/E)

-0.48 (60.32%)

-1.2 (81.92%)

-6.65

-

Price to Sales Ratio (P/S)

32.99 (61.68%)

20.41 (-91.45%)

238.71

-

Price to Book Ratio (P/B)

1 (-84.81%)

6.58 (-39.98%)

10.97

-

Debt to Equity Ratio (D/E)

0.76 (-62.97%)

2.05 (274.91%)

0.55 (-79.01%)

2.6 (105.57%)

Earnings Per Share (EPS)

-2.43 (53.27%)

-5.2 (-1.96%)

-5.1 (-2.00%)

-5 (-138.10%)

Sales Per Share (SPS)

0.04 (-88.56%)

0.31 (115.49%)

0.14 (-42.04%)

0.24 (-38.90%)

Free Cash Flow Per Share (FCFPS)

-0.98 (58.64%)

-2.37 (21.91%)

-3.04 (-31.32%)

-2.31 (-29.26%)

Book Value Per Share (BVPS)

1.94 (97.65%)

0.98 (-72.27%)

3.53 (102.41%)

1.74 (2127.91%)

Tangible Assets Book Value Per Share (TABVPS)

3.34 (10.51%)

3.02 (-44.68%)

5.47 (-7.12%)

5.89 (48.70%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0.00%)

-1 (87.50%)

-8

-

Enterprise Value Over EBITDA (EV/EBITDA)

-1.38 (1.92%)

-1.41 (82.71%)

-8.14

-

Asset Turnover

0.01 (-85.71%)

0.08 (170.97%)

0.03 (-40.38%)

0.05

Current Ratio

0.28 (-48.24%)

0.54 (-74.00%)

2.07 (62.72%)

1.27 (887.60%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$4,257,046 (43.38%)

-$7,518,083 (1.28%)

-$7,615,222 (-66.86%)

-$4,563,919 (-45.60%)

Enterprise Value (EV)

$10,674,434 (-50.43%)

$21,535,239 (-77.53%)

$95,831,749

-

Earnings Before Tax (EBT)

-$10,259,650 (34.34%)

-$15,625,461 (-30.06%)

-$12,013,789 (-20.00%)

-$10,011,516 (-169.21%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$7,737,779 (49.45%)

-$15,307,694 (-30.01%)

-$11,774,586 (-23.04%)

-$9,569,342 (-200.76%)

Invested Capital

$10,121,318 (77.59%)

$5,699,109 (-13.02%)

$6,552,405 (-20.52%)

$8,243,888 (81.88%)

Working Capital

-$4,275,781 (-67.26%)

-$2,556,381 (-164.53%)

$3,961,470 (198.17%)

$1,328,575 (122.38%)

Tangible Asset Value

$14,492,599 (51.29%)

$9,579,574 (-30.07%)

$13,698,033 (18.02%)

$11,606,705 (67.54%)

Market Capitalization

$8,389,050 (-58.87%)

$20,395,206 (-78.97%)

$96,985,825

-

Average Equity

$4,694,770 (-27.15%)

$6,444,617 (20.18%)

$5,362,454 (226.25%)

$1,643,688

Average Assets

$12,784,862 (11.39%)

$11,477,377 (0.85%)

$11,380,969 (22.81%)

$9,267,258

Invested Capital Average

$10,174,526 (32.16%)

$7,698,591 (-4.48%)

$8,059,836 (26.17%)

$6,388,234

Shares

7,231,940 (121.62%)

3,263,233 (14.06%)

2,860,939

-